欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/2136/001
药品名称Gemcitabine Accord 100 mg/ml
活性成分
    • gemcitabine hydrochloride 100.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV UTRECHT The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Gemcitabine Accord 100 mg/ml concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    • Portugal (PT)
    • Germany (DE)
      Gemcitabine Accord 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
    • Ireland (IE)
    • Austria (AT)
      Gemcitabin Accord 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Italy (IT)
    • Belgium (BE)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Gemcitabine Accord 100 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      GEMCITABINE ACCORD 100MG/ML
    • Hungary (HU)
      GEMCITABINE ACCORD 100 mg/ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Gemcitabine Accord
    • Cyprus (CY)
      GEMCITABINE ACCORD 100mg CON FOR SOL FOR INF
    • Czechia (CZ)
      Gemcitabine Accord 100 mg/ml Koncentrát pro Přípravu Infuzního Roztoku
    • Romania (RO)
      Gemcitabina Accord 100 mg/ ml concentrat pentru solutie perfuzabila
    • Slovakia (SK)
      Gemcitabine Accord 100 mg/ml infúzny koncentát
许可日期2012/01/31
最近更新日期2024/03/20
药物ATC编码
    • L01BC05 gemcitabine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase